Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
HZNP was delisted on the 5th of October, 2023.
136 hedge funds and large institutions have $1.14B invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2014 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 51 increasing their positions, 36 reducing their positions, and 27 closing their positions.
291% more call options, than puts
Call options by funds: $30.3M | Put options by funds: $7.74M
67% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 27
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
53% more capital invested
Capital invested by funds: $741M → $1.14B (+$396M)
42% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 36
13% more funds holding
Funds holding: 120 → 136 (+16)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$77.3M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$49.2M |
| 3 |
BC
Broadfin Capital
New York
|
+$47.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.1M |
| 5 |
HM
HealthCor Management
New York
|
+$25.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
-$15.8M |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$10.7M |
| 3 |
FAM
Fred Alger Management
New York
|
-$5.31M |
| 4 |
Millennium Management
New York
|
-$4.18M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.8M |
HZNP Hedge Fund Activity: Q4 2014 in Review
136 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q4 2014, worth a combined $1.14B — up 53% from $741M a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new HZNP positions and 27 closed out — a net gain of 18 holders — while 51 added to existing stakes and 36 trimmed.
The largest buyer was Deerfield Management, adding an estimated $77.3M. The largest seller was Chartwell Investment Partners, exiting entirely with an estimated $15.8M sold.
- 136 institutional investors held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q4 2014, up from 120 in Q3 2014.
- Funds reported $1.14B of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q4 2014, up 53% quarter-over-quarter.
- 45 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q4 2014 and 27 closed out, a net change of +18 holders.
- The largest Horizon Therapeutics Public Limited Company Ordinary Shares buyer in Q4 2014 was Deerfield Management, an estimated $77.3M added.
- The largest Horizon Therapeutics Public Limited Company Ordinary Shares seller in Q4 2014 was Chartwell Investment Partners, an estimated $15.8M sold.
Based on aggregated 13F filings for Q4 2014.